- Eucomed data reports. Period: 2005-2013
- NJR data extract, March 2014 – analysed by Biomet
- Danish Hip Arthroplasty Register, Annual Report, 2011
- Mukka, S. et al. Dual Mobility Cups for Preventing Early Hip Arthroplasty Dislocation in Patients at Risk: Experience in a County Hospital. Orthopedic Reviews (Pavia). 5(2): e10, 2013.
- https://www.odep.org.uk
- Swedish Hip Arthroplasty Registry (2012)
- National Joint Registry for England Wales and Northern Island, 10th Annual Report, 2013
- Danish Hip Arthroplasty Register, Annual Report, 2011
- Biomet Market Analysis
- Data on File at Biomet. Push-in /lever-out Avantage test report MT 5357 not necessarily indicative of clinical performance.
- Beaule, et al. Jumbo femoral head for the treatment of recurrent dislocation following total hip replacement. J Bone Joint Surg February 2002; 84-A: 2, pp. 256–63.
- Burroughs BR, et al. Range of motion and stability in total hip arthroplasty with 28, 32, 38, and 44mm femoral head sizes: An in vitro study. The Journal of Arthroplasty, January 2005; Vol. 20, Issue 1, Pages 11-19.
Avantage Dual Mobility Cup System
Overview
12-16% of revision surgeries are due to dislocation6-8. In Europe it is estimated to cause suffering for 12,000 – 22,000 patients and €58M-€78M annually to healthcare providers9.
Biomet introduced the Avantage system in 1998 to address patients with high risk of dislocation. Avantage is a dual mobility acetabular system combining a proprietary anatomical cup design and a unique ultra-low wear polyethylene. Since 2005, the Avantage system has been the N°1 cementless and cemented dual mobility cup on the market1.
The Avantage double mobility cup system is an optimal solution for the treatment of patients with a high risk of dislocation or recurrent dislocation10. Its anatomic design offers joint stability11 and a large range of motion12. From primary to more complex revision and reconstruction cases, the comprehensive Avantage double mobility system addresses most surgical needs.
Clinical Success
96.9%
Survival rate @ 9 years, National Joint Registry - England, Wales and NI2
Clinical Success
0.36%
Dislocation rate4
Clinical Success
96.3%
Survival rate @ mean 7.2 years, Fresard et al, Multicentre Study3
Features
- Superior Cap helps reduce risk of superior dislocation
- Anatomic aperture helps reduce risk of impingement and increases ROM
- Flattened pole helps increase peripheral load
- Smooth superior-inferior transition helps reduce soft tissue irritation
- E1® Antioxidant Infused Polyethylene
You might also be interested in